Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line

Anticancer Res. 1998 May-Jun;18(3A):1765-8.

Abstract

A cisplatin (CDDP)-resistant human osteosarcoma cell line (OST/R) was established by continuous exposure to CDDP. OST/R cells proved to be 6.73 times more resistant to CDDP compared with parental OST cells, and showed cross-resistance to carboplatin (CBDCA). The mechanism of CDDP resistance was a significant decrease of intracellular platinum accumulation which was 40% of that in OST cells. OST/R cells were exposed to CDDP for 6 hours, the platinum was released from the cytoplasm of OST/R cells without reaching a state of equilibrium. DNA synthesis in OST/R cells was not inhibited by CDDP exposure, while in OST cells it was reduced by 50%. These data provide the first evidence that the increased efflux of platinum may play an important role in CDDP-resistance.

MeSH terms

  • Antineoplastic Agents / toxicity*
  • Biological Transport
  • Bone Neoplasms
  • Carboplatin / pharmacokinetics
  • Carboplatin / toxicity*
  • Cell Line
  • Cisplatin / pharmacokinetics*
  • Cisplatin / toxicity*
  • Cytoplasm / metabolism
  • DNA, Neoplasm / biosynthesis
  • Drug Resistance, Neoplasm*
  • Humans
  • Kinetics
  • Osteosarcoma
  • Platinum / metabolism
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • Antineoplastic Agents
  • DNA, Neoplasm
  • Platinum
  • Carboplatin
  • Cisplatin